Skip to main content

Table 3 Key safety outcomes (n = 21)

From: Sacubitril/valsartan is well tolerated in patients with longstanding heart failure and history of cancer and improves ventricular function: real-world data

 

Baseline

Follow-up

P

Creatinine, mg/dl

1.18 ± 0.4

1.22 ± 0.4

0.566

Serum potassium, mmol per liter

4.52 ± 0.4

4.50 ± 0.4

0.776

Systolic blood pressure, mmHg

124 ± 15

115 ± 15

0.003

Heart rate, bpm

72 ± 14

70 ± 11

0.494

Back to article page

Cardio-Oncology

ISSN: 2057-3804

Contact us